Clinical Trial Detail

NCT ID NCT03128034
Title 211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Fred Hutchinson Cancer Research Center
Indications

myelodysplastic syndrome

myelodysplastic/myeloproliferative neoplasm

acute myeloid leukemia

acute lymphoblastic leukemia

Therapies

Cyclosporine + Fludarabine + Mycophenolate mofetil + Sirolimus

Age Groups: senior adult

No variant requirements are available.